表紙
市場調査レポート

経腸栄養製剤の世界市場 - 2020年までの予測:製品 (高分子・単量体・疾患特異的製剤) 、段階、応用 (腫瘍、消化器、神経)、エンドユーザー、地域別

Enteral Feeding Formulas Market by Product (Polymeric, Monomeric, Disease-Specific Formulas), by Stage (Adults, Pediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospitals, LTCS, Home Care) - Global Forecast to 2020

発行 MarketsandMarkets 商品コード 354058
出版日 ページ情報 英文 226 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
経腸栄養製剤の世界市場 - 2020年までの予測:製品 (高分子・単量体・疾患特異的製剤) 、段階、応用 (腫瘍、消化器、神経)、エンドユーザー、地域別 Enteral Feeding Formulas Market by Product (Polymeric, Monomeric, Disease-Specific Formulas), by Stage (Adults, Pediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospitals, LTCS, Home Care) - Global Forecast to 2020
出版日: 2016年03月08日 ページ情報: 英文 226 Pages
概要

世界の経腸栄養製剤市場は、2020年までに59億5千万米ドルに達し、2015年〜2020年のCAGR (複合年間成長率) で7.6%の成長が予測されています。市場の主要促進要因として、慢性疾患の罹患率の上昇、高齢者人口の急増、医療費の増加、早産の有病率の急増、在宅介護の需要の増加などが挙げられます。

当レポートでは、世界の経腸栄養製剤市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 経腸栄養製剤市場の概要
  • アジア太平洋地域の経腸栄養製剤市場:応用別
  • 経腸栄養製剤市場の地域別概要
  • 北米が経腸栄養製剤市場で優勢
  • 経腸栄養製剤市場:発展途上国 vs. 先進国

第5章 市場概要

  • イントロダクション
  • 市場区分
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題

第6章 産業動向

  • イントロダクション
  • 産業動向
  • 戦略的ベンチマーキング
  • 規制・償還シナリオ

第7章 世界の経腸栄養製剤市場:段階別

  • イントロダクション
  • 成人
  • 小児

第8章 世界の経腸栄養製剤市場:製品別

  • イントロダクション
  • 標準製剤
  • 疾患特異的製剤

第9章 世界の経腸栄養製剤市場:応用別

  • イントロダクション
  • 腫瘍
  • 消化器
  • 神経
  • 糖尿病
  • 救命医療
  • その他

第10章 世界の経腸栄養製剤市場:エンドユーザー別

  • イントロダクション
  • 病院
  • 長期療養施設

第11章 世界の経腸栄養製剤市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第12章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合状況と動向

第13章 企業プロファイル (財務、製品・サービス、主な戦略、最近の発展など)

  • イントロダクション
  • ABBOTT LABORATORIES
  • NESTLE S.A.
  • DANONE S.A.
  • FRESENIUS KABI AG
  • MEAD JOHNSON NUTRITION COMPANY
  • B. BRAUN MELSUNGEN AG
  • HORMEL FOODS CORPORATION
  • 明治ホールディングス
  • VICTUS, INC.
  • GLOBAL HEALTH PRODUCTS, INC.

第14章 付録

図表

目次
Product Code: PH 4148

The global enteral feeding formulas market is expected to grow at a CAGR of 7.6% during the forecast period of 2015-2020 and is estimated to be worth USD 5.95 billion by 2020. The market is mainly driven by factors such as rising incidences of chronic diseases and disorders, rapidly growing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare. However, factors such as complications associated with enteral nutrition, patient safety risks, and the risk of feeding and medication errors are some restraints for the growth of the enteral feeding formulas market.

In this report, the global enteral feeding formulas market is segmented by product, stage, application, end user, and region.

On the basis of products, the market is classified into standard and disease-specific formulas. The standard formulas segment is further segmented into polymeric and monomeric formulas. The disease-specific formulas included in this report are subdivided into diabetic, renal, hepatic, pulmonary, and other formulas, which primarily include immune-enhancing & wound-healing formulas and formulas for critical care. On the basis of stage, the enteral feeding formulas market is segmented into adults and pediatrics. On the basis of applications, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. By end user, the enteral feeding formulas market is segmented into hospitals and long-term care facilities. Long-term care facilities are further segmented into homecare agencies & hospices and nursing homes and assisted living facilities.

Geographically, North America accounted for the largest share of the global enteral feeding formulas market in 2015, followed by Europe, Asia-Pacific, and RoW. Developed geographies like North America and Europe are likely to grow at a lower CAGR as compared to the Asia-Pacific market. The Asia-Pacific region is expected to record the highest market growth during the forecast period due to the presence of a large patient pool for chronic diseases and disorders, high incidences of preterm births, growing healthcare expenditure, rapidly developing healthcare infrastructure, increasing per capita income, growing middle-class population, and growing population in emerging APAC countries.

In 2015, Abbott Laboratories (U.S.), Nestle S.A. (Switzerland), Danone S.A. (France), and Fresenius Kabi AG (Germany) were the leading players in the enteral feeding formulas market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the enteral feeding formulas market. The report analyzes the enteral feeding formulas market by stage, product, application, and end user across all regions
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and new product launches in the enteral feeding formulas market
  • Market Development: Comprehensive information of the lucrative emerging markets by stage, product, application, end user, and region
  • Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the global enteral feeding formulas market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, and manufacturing capabilities of the leading players in the global enteral feeding formulas market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
    • 2.4.1. KEY DATA FROM SECONDARY SOURCES
    • 2.4.2. KEY DATA FROM PRIMARY SOURCES
    • 2.4.3. KEY INDUSTRY INSIGHTS FROM PRIMARY SOURCES
    • 2.4.4. ASSUMPTION FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ENTERAL FEEDING FORMULAS MARKET OVERVIEW
  • 4.2. ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE ENTERAL FEEDING FORMULAS MARKET
  • 4.4. NORTH AMERICA TO DOMINATE THE ENTERAL FEEDING FORMULAS MARKET DURING THE FORECAST PERIOD
  • 4.5. ENTERAL FEEDING FORMULAS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY STAGE
    • 5.2.2. BY PRODUCT
    • 5.2.3. BY APPLICATION
    • 5.2.4. BY END USER
  • 5.3. MARKET DYNAMICS
    • 5.3.1. MARKET DRIVERS
      • 5.3.1.1. Rising geriatric population across the globe
      • 5.3.1.2. High prevalence of chronic diseases and disorders
      • 5.3.1.3. Increasing healthcare expenditure
      • 5.3.1.4. Growing number of preterm births
      • 5.3.1.5. Increasing demand for homecare
    • 5.3.2. MARKET RESTRAINTS
      • 5.3.2.1. Complications associated with enteral feeding
      • 5.3.2.2. Patient safety risks and occurrence of feeding/medication errors associated with enteral feeding devices
    • 5.3.3. MARKET OPPORTUNITIES
      • 5.3.3.1. Growth in healthcare expenditure of emerging economies
      • 5.3.3.2. Increasing demand for personalized medicine
    • 5.3.4. MARKET CHALLENGES
      • 5.3.4.1. Insufficient reimbursements

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. INDUSTRY TRENDS
    • 6.2.1. SHIFT FROM PARENTERAL TO ENTERAL NUTRITION
    • 6.2.2. MICROENCAPSULATION
  • 6.3. STRATEGIC BENCHMARKING
    • 6.3.1. PRODUCT PORTFOLIO ANALYSIS: ENTERAL FEEDING FORMULAS MARKET
  • 6.4. REGULATORY AND REIMBURSEMENT SCENARIO
    • 6.4.1. REGULATORY ANALYSIS
    • 6.4.2. REIMBURSEMENT ANALYSIS

7. GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY STAGE

  • 7.1. INTRODUCTION
  • 7.2. ADULTS
  • 7.3. PEDIATRICS

8. GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT

  • 8.1. INTRODUCTION
  • 8.2. STANDARD FORMULAS
    • 8.2.1. POLYMERIC FORMULAS
    • 8.2.2. MONOMERIC FORMULAS
  • 8.3. DISEASE-SPECIFIC FORMULAS
    • 8.3.1. DIABETIC FORMULAS
    • 8.3.2. RENAL FORMULAS
    • 8.3.3. HEPATIC FORMULAS
    • 8.3.4. PULMONARY FORMULAS
    • 8.3.5. OTHER FORMULAS

9. GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. ONCOLOGY
  • 9.3. GASTROENTEROLOGY
  • 9.4. NEUROLOGY
  • 9.5. DIABETES
  • 9.6. CRITICAL CARE
  • 9.7. OTHER APPLICATIONS

10. GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. HOSPITALS
  • 10.3. LONG-TERM CARE FACILITIES
    • 10.3.1. HOME CARE AGENCIES AND HOSPICES
    • 10.3.2. NURSING HOMES
    • 10.3.3. ASSISTED LIVING FACILITIES

11. GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. FRANCE
    • 11.3.3. U.K.
    • 11.3.4. ITALY
    • 11.3.5. SPAIN
    • 11.3.6. REST OF EUROPE
  • 11.4. ASIA-PACIFIC
    • 11.4.1. JAPAN
    • 11.4.2. CHINA
    • 11.4.3. INDIA
    • 11.4.4. REST OF ASIA-PACIFIC
  • 11.5. REST OF THE WORLD
    • 11.5.1. LATIN AMERICA
    • 11.5.2. MIDDLE EAST AND AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET SHARE ANALYSIS
  • 12.3. COMPETITIVE SITUATION AND TRENDS
    • 12.3.1. NEW PRODUCT LAUNCHES
    • 12.3.2. EXPANSIONS
    • 12.3.3. PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 12.3.4. ACQUISITIONS

13. COMPANY PROFILES*

  • 13.1. INTRODUCTION
  • 13.2. ABBOTT LABORATORIES
  • 13.3. NESTLE S.A.
  • 13.4. DANONE S.A.
  • 13.5. FRESENIUS KABI AG
  • 13.6. MEAD JOHNSON NUTRITION COMPANY
  • 13.7. B. BRAUN MELSUNGEN AG
  • 13.8. HORMEL FOODS CORPORATION
  • 13.9. MEIJI HOLDINGS CO., LTD.,
  • 13.10. VICTUS, INC.
  • 13.11. GLOBAL HEALTH PRODUCTS, INC.

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. AVAILABLE CUSTOMIZATIONS
  • 14.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: ENTERAL FEEDING FORMULAS MARKET SNAPSHOT, 2015 VS. 2020
  • TABLE 2: COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING
  • TABLE 3: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 4: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR ADULTS, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 5: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR PEDIATRICS, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 6: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 7: GLOBAL STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 8: GLOBAL STANDARD FORMULAS MARKET SIZE, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 9: GLOBAL POLYMERIC FORMULAS MARKET SIZE, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 10: GLOBAL MONOMERIC FORMULAS MARKET SIZE, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 11: GLOBAL DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 12: GLOBAL DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 13: GLOBAL DIABETIC FORMULAS MARKET SIZE, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 14: GLOBAL RENAL FORMULAS MARKET SIZE, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 15: GLOBAL RENAL FORMULAS MARKET SIZE, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 16: GLOBAL PULMONARY FORMULAS MARKET SIZE, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 17: GLOBAL OTHER DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 18: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 19: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR ONCOLOGY, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 20: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR GASTROENTEROLOGY, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 21: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR NEUROLOGY, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 22: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR DIABETES, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 23: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR CRITICAL CARE, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 24: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 25: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 26: U.S.: NUMBER OF HOSPITAL DISCHARGES FOR CHRONIC DISEASES AND DISORDERS, 2013
  • TABLE 27: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR HOSPITALS, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 28: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 29: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 30: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR HOME CARE & HOSPICES, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 31: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR NURSING HOMES, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 32: GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR ASISTED LIVING FACILITIES, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 33: NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 34: NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 35: NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 36: NORTH AMERICA: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 37: NORTH AMERICA: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 38: NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 39: NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 40: NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 41: U.S.: MARKET INDICATORS
  • TABLE 42: U.S.: CHRONIC DISEASES AND DISORDERS STATISTICS
  • TABLE 43: U.S.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 44: U.S.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 45: U.S.: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 46: U.S.: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 47: U.S.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 48: U.S.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 49: U.S.: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 50: CANADA: MARKET INDICATORS
  • TABLE 51: CANADA: CHRONIC DISEASES AND DISORDERS STATISTICS
  • TABLE 52: CANADA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 53: CANADA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 54: CANADA: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 55: CANADA: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 56: CANADA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 57: CANADA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 58: CANADA: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 59: EUROPE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 60: EUROPE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 61: EUROPE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 62: EUROPE: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 63: EUROPE: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 64: EUROPE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 65: EUROPE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 66: EUROPE: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 67: GERMANY: MARKET INDICATORS
  • TABLE 68: GERMANY: CHRONIC DISEASES AND DISORDERS STATISTICS
  • TABLE 69: GERMANY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 70: GERMANY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 71: GERMANY: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 72: GERMANY: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 73: GERMANY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 74: GERMANY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 75: GERMANY: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 76: FRANCE: MARKET INDICATORS
  • TABLE 77: FRANCE: CHRONIC DISEASES AND DISORDERS STATISTICS
  • TABLE 78: FRANCE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 79: FRANCE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 80: FRANCE: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 81: FRANCE: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 82: FRANCE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 83: FRANCE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 84: FRANCE: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 85: U.K.: MARKET INDICATORS
  • TABLE 86: U.K.: CHRONIC DISEASES AND DISORDERS STATISTICS
  • TABLE 87: U.K.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 88: U.K.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 89: U.K.: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 90: U.K.: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 91: U.K.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 92: U.K.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 93: U.K.: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 94: ITALY: MARKET INDICATORS
  • TABLE 95: ITALY: CHRONIC DISEASES AND DISORDERS STATISTICS
  • TABLE 96: ITALY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 97: ITALY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 98: ITALY: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 99: ITALY: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 100: ITALY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 101: ITALY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 102: ITALY: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 103: SPAIN: MARKET INDICATORS
  • TABLE 104: SPAIN: CHRONIC DISEASES AND DISORDERS STATISTICS
  • TABLE 105: SPAIN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 106: SPAIN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 107: SPAIN: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 108: SPAIN: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 109: SPAIN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 110: SPAIN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 111: SPAIN: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 112: ROE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 113: ROE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 114: ROE: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 115: ROE: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 116: ROE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 117: ROE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 118: ROE: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 119: APAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 120: APAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 121: APAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 122: APAC: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 123: APAC: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 124: APAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 125: APAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 126: APAC: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 127: JAPAN: MARKET INDICATORS
  • TABLE 128: JAPAN: CHRONIC DISEASES AND DISORDERS STATISTICS
  • TABLE 129: JAPAN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 130: JAPAN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 131: JAPAN: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 132: JAPAN: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 133: JAPAN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 134: JAPAN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 135: JAPAN: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 136: CHINA: MARKET INDICATORS
  • TABLE 137: CHINA: CHRONIC DISEASES AND DISORDERS STATISTICS
  • TABLE 138: CHINA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 139: CHINA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 140: CHINA: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 141: CHINA: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 142: CHINA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 143: CHINA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 144: CHINA: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 145: INDIA: MARKET INDICATORS
  • TABLE 146: INDIA: CHRONIC DISEASES AND DISORDERS STATISTICS
  • TABLE 147: INDIA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 148: INDIA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 149: INDIA: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 150: INDIA: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 151: INDIA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 152: INDIA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 153: INDIA: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 154: ROAPAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 155: ROAPAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 156: ROAPAC: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 157: ROAPAC: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 158: ROAPAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 159: ROAPAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 160: ROAPAC: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 161: ROW: ENTERAL FEEDING FORMULAS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 162: ROW: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 163: ROW: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 164: ROW: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 165: ROW: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 166: ROW: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 167: ROW: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 168: ROW: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 169: LATIN AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 170: LATIN AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 171: LATIN AMERICA: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 172: LATIN AMERICA: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 173: LATIN AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 174: LATIN AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 175: LATIN AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 176: MIDDLE EAST AND AFRICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2013-2020 (USD MILLION)
  • TABLE 177: MIDDLE EAST AND AFRICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 178: MIDDLE EAST AND AFRICA: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 179: MIDDLE EAST AND AFRICA: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 180: MIDDLE EAST AND AFRICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 181: MIDDLE EAST AND AFRICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 182: MIDDLE EAST AND AFRICA: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 183: GROWTH STRATEGY MATRIX (2012-2015)
  • TABLE 184: NEW PRODUCT LAUNCHES, 2012-2015
  • TABLE 185: EXPANSIONS, 2012-2015
  • TABLE 186: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2012-2015
  • TABLE 187: ACQUISITONS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: ENTERAL FEEDING FORMULAS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 8: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION)
  • FIGURE 9: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 10: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 11: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 12: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION)
  • FIGURE 13: LONG-TERM CARE FACILITIES MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 14: GEOGRAPHIC ANALYSIS: GLOBAL ENTERAL FEEDING FORMULAS MARKET
  • FIGURE 15: RISING PREVALENCE OF CHRONIC DISEASES AND DISORDERS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: JAPAN IS ESTIMATED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET IN 2015
  • FIGURE 17: U.S. IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL ENTERAL FEEDING FORMULAS MARKET IN 2015
  • FIGURE 18: ENTERAL FEEDING FORMULAS MARKET: GEOGRAPHIC MIX
  • FIGURE 19: CHINA TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 20: ENTERAL FEEDING FORMULAS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 21: GLOBAL ELDERLY POPULATION, BY REGION
  • FIGURE 22: INCREASING GLOBAL HEALTHCARE EXPENDITURE
  • FIGURE 23: PRETERM BIRTH STATISTICS (DEVELOPED COUNTRIES, LATIN AMERICA, AND CARIBBEAN), 1990-2025
  • FIGURE 24: PRETERM BIRTH STATISTICS, BY COUNTRY, 1990-2010
  • FIGURE 25: HEALTHCARE EXPENDITURE GROWTH RATE ACROSS KEY GEOGRAPHIES
  • FIGURE 26: GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 27: GLOBAL PREVALENCE OF UNDERWEIGHT CHILDREN, 1990 VS. 2015
  • FIGURE 28: GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2015 VS. 2020 (USD MILLION) 65  
  • FIGURE 29: GLOBAL STANDARD FORMULAS MARKET, BY TYPE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 30: GLOBAL DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 31: GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 32: RISING PREVALENCE OF CANCER ACROSS KEY REGIONS FROM 2008 TO 2012
  • FIGURE 33: U.S.: NUMBER OF HOSPITAL DISCHARGES FOR GASTROINTESTINAL TRACT DISEASES (2006-2013)
  • FIGURE 34: GLOBAL POPULATION LIVING WITH DEMENTIA, 2015
  • FIGURE 35: TOP TEN DIABETIC COUNTRIES (20-79 YEARS) IN 2015
  • FIGURE 36: GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2015 VS. 2020 (USD MILLION)
  • FIGURE 37: U.S.: NUMBER OF REGISTERED HOSPITALS (2006-2013)
  • FIGURE 38: GLOBAL ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 39: U.S.: NUMBER OF HOME CARE AGENCIES (2006-2014)
  • FIGURE 40: U.S.: NUMBER OF NURSING HOMES (2006-2014)
  • FIGURE 41: U.S.: NUMBER OF ASSISTED LIVING FACILITIES (2006-2014)
  • FIGURE 42: GEOGRAPHIC SNAPSHOT (2015-2020): ASIA-PACIFIC, AN EMERGING GROWTH HOTSPOT
  • FIGURE 43: NORTH AMERICAN ENTERAL FEEDING FORMULAS MARKET SNAPSHOT, 2015
  • FIGURE 44: NORTH AMERICA: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 45: U.S.: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 46: CANADA: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 47: EUROPE: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 48: GERMANY: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 49: FRANCE: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 50: U.K.: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 51: ITALY: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 52: SPAIN: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 53: ROE: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 54: ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET SNAPSHOT, 2015
  • FIGURE 55: APAC: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 56: JAPAN: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 57: CHINA: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 58: INDIA: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 59: ROAPAC: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 60: LATIN AMERICA: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 61: MIDDLE EAST AND AFRICA: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 62: NEW PRODUCT LAUNCHES AND EXPANSIONS WERE THE KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS IN THE LAST THREE YEARS (2012-2015)
  • FIGURE 63: GLOBAL ENTERAL FEEDING FORMULAS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 187  
  • FIGURE 64: GEOGRAPHIC REVENUE MIX OF THE TOP FOUR PLAYERS
  • FIGURE 65: COMPANY SNAPSHOT: ABBOTT LABORATORIES
  • FIGURE 66: COMPANY SNAPSHOT: NESTLE S.A.
  • FIGURE 67: COMPANY SNAPSHOT: DANONE S.A.
  • FIGURE 68: COMPANY SNAPSHOT: FRESENIUS KABI AG
  • FIGURE 69: COMPANY SNAPSHOT: MEAD JOHNSON NUTRITION COMPANY
  • FIGURE 70: COMPANY SNAPSHOT: B. BRAUN MELSUNGEN AG
  • FIGURE 71: COMPANY SNAPSHOT: HORMEL FOODS CORPORATION
  • FIGURE 72: COMPANY SNAPSHOT: MEIJI HOLDINGS CO., LTD.
Back to Top